Abstract:Xylans, a family of xylose-based polysaccharides, are dietary fibers resistant to digestion. They therefore reach the large intestine intact; there, they are utilized by members of the gut microbiota. They are initially broken down by primary degraders that utilize extracellular xylanases to cleave xylan into smaller oligomers. The resulting xylooligosaccharides (XOS) can either be further metabolized directly by primary degraders or cross-feed secondary consumers, including Bifidobacterium. While several Bifidobacterium species have metabolic systems for XOS, most grow poorly on longer-chain XOS and xylan substrates. In this study, we isolated strains of Bifidobacterium pseudocatenulatum and observed that some, including B. pseudocatenulatum ED02, displayed growth on XOS with a high degree of polymerization (DP) and straight-chain xylan, suggesting a primary degrader phenotype that is rare in Bifidobacterium. In silico analyses revealed that only the genomes of these xylan-fermenting (xylan+) strains contained an extracellular GH10 endo-β-1.4 xylanase, a key enzyme for primary degradation of xylan. The presence of an extracellular xylanase was confirmed by the appearance of xylan hydrolysis products in cell-free supernatants. Extracellular xylanolytic activity was only detected in xylan+ strains, as indicated by the production of XOS fragments with a DP of 2 to 6, identified by thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC). Additionally, in vitro fecal fermentations revealed that strains with a xylan+ phenotype can persist with xylan supplementation. These results indicate that xylan+ B. pseudocatenulatum strains may have a competitive advantage in the complex environment of the gastrointestinal tract, due to their ability to act as primary degraders of xylan through extracellular enzymatic degradation. IMPORTANCE The beneficial health effects of dietary fiber are now well established. Moreover, low fiber consumption is associated with increased risks of metabolic and systemic diseases. This so-called "fiber gap" also has a profound impact on the composition of the gut microbiome, leading to a disrupted or dysbiotic microbiota. Therefore, understanding the mechanisms by which keystone bacterial species in the gut utilize xylans and other dietary fibers may provide a basis for developing strategies to restore gut microbiome function. The results described here provide biochemical and genetic evidence for primary xylan utilization by human-derived Bifidobacterium pseudocatenulatum and show also that cooperative utilization of xylans occurs among other members of this species.

Possible Beneficial Effects of Xyloglucan from Its Degradation by Gut Microbiota

Gut Microbial Utilization of Xylan and Its Implication in Gut Homeostasis and Metabolic Response

Chemical modifications of xylan from sugarcane bagasse and their regulatory effects on gut microbiota in mice

Effect of Glycoside Hydrolase-Mediated Wheat Arabinoxylan Hydrolysate on Gut Microbiota and Metabolite Profiles

The prebiotic impacts of galactose side-chain of tamarind xyloglucan oligosaccharides on gut microbiota

Xylan Prebiotics and the Gut Microbiome Promote Health and Wellbeing: Potential Novel Roles for Pentosan Polysulfate

Adaptation of Syntenic Xyloglucan Utilization Loci of Human Gut Bacteroidetes to Polysaccharide Side Chain Diversity

Interaction of beta-glucans with gut microbiota: Dietary origins, structures, degradation, metabolism, and beneficial function

Xanthan Gum Oligosaccharides Ameliorate Glucose Metabolism and Related Gut Microbiota Dysbiosis in Type 2 Diabetic Mice

Digestive characteristics of Gastrodia elata Blume polysaccharide and related impacts on human gut microbiota in vitro

Polysaccharides Influence Human Health Via Microbiota-Dependent and -Independent Pathways.

Physiology function of gastrointestinal effects of β-glucan

Studies of Peach Gum Polysaccharide on Gut Microbiota in Vitro Fermentation by Human Feces

Regulation effects of indigestible dietary polysaccharides on intestinal microflora: An overview.

Effects of Polysaccharides on Glycometabolism Based on Gut Microbiota Alteration

Role of Bifidobacterium pseudocatenulatum in Degradation and Consumption of Xylan-Derived Carbohydrates

Effect of Partially Hydrolyzed Guar Gum on the Composition and Metabolic Function of the Intestinal Flora of Healthy Mice.

The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review

Xylan utilisation promotes adaptation of Bifidobacterium pseudocatenulatum to the human gastrointestinal tract

Beyond cellulose: pharmaceutical potential for bioactive plant polysaccharides in treating disease and gut dysbiosis

Xyloglucan Compounded Inulin or Arabinoxylan Against Glycometabolism Disorder Via Different Metabolic Pathways: Gut Microbiota and Bile Acid Receptor Effects